RHHVF (RHHVF) Stock Price & Analysis
RHHVF (RHHVF) rose 0.35% to USD 409 as of June 10, 2026 at 00:51 UTC, according to Nexqual real-time market data.
RHHVF last closed at USD 407.56; the session ranged USD 409–409 on volume of 10 shares. Market capitalization is $329.01B, with a 52-week range of USD 300.15–490.33 (OQX). Source: Nexqual, June 10, 2026 at 00:51 UTC.
Key Statistics (as of June 10, 2026 at 00:51 UTC)
| Price | USD 409 |
|---|---|
| Change | ▲ 0.35% (up) |
| Previous Close | USD 407.56 |
| Open | USD 409 |
| Day Range | USD 409 – 409 |
| 52-Week Range | USD 300.15 – 490.33 |
| Volume | 10 shares |
| Market Cap | $329.01B |
| Exchange | OQX |
Technical Analysis (RHHVF)
Nexqual's technical model rates RHHVF "NEUTRAL" based on 3 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 00:51 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.69 (neutral) |
| vs SMA50 | Above (USD 404.6) |
| MACD | -0.89 (negative) |
Analyst Ratings (RHHVF)
Wall Street analysts rate RHHVF "None" based on 1 analysts, with a mean price target of USD 475.39 (range USD 475.39–475.39), per Nexqual as of June 10, 2026 at 00:51 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 475.39 |
| High Target | USD 475.39 |
| Low Target | USD 475.39 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (RHHVF)
| Revenue Estimate | $15.60B |
|---|
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financials & Fundamentals (RHHVF)
| Total Revenue | $63.36B |
|---|---|
| Revenue Growth (YoY) | -0.40% |
| Gross Margin | +74.49% |
| Operating Margin | +29.99% |
| Profit Margin | +20.33% |
| ROE | +37.27% |
| Debt / Equity | 87.64 |
| Current Ratio | 1.38 |
| Total Cash | $15.49B |
| Total Debt | $33.20B |
| Free Cash Flow | $11.03B |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financial Health Score (RHHVF)
Nexqual rates RHHVF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:51 UTC.
| Growth | Mixed — Revenue +1.7% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 74%, operating 30% |
| Balance Sheet | Mixed — $15.5B cash vs $33.2B debt |
| Cash Flow | Strong — FCF $11.0B, 18% margin |
| Efficiency | Strong — ROE 37%, ROA 12.9% |
Ownership (RHHVF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +44.30% |
| Shares Outstanding | 688.93M |
| Float | 652.94M |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Leadership (RHHVF)
RHHVF is led by Thomas Schinecker (age 50), Group Chief Executive Officer, per Nexqual as of June 10, 2026 at 00:51 UTC.
| Group Chief Executive Officer | Thomas Schinecker (age 50) |
|---|---|
| Executive Chairman | Severin Schwan (age 58) |
| Chief Financial Officer | Alan Hippe (age 58) |
Major Backers & Investors (RHHVF)
Notable institutional backers of RHHVF include Fidelity, Dodge & Cox Funds-Dodge & Cox International Stock Fund, MFS Series Trust XVII-MFS International Equity Fund, according to Nexqual as of June 10, 2026 at 00:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.78% |
| Dodge & Cox Funds-Dodge & Cox International Stock Fund | 0.43% |
| MFS Series Trust XVII-MFS International Equity Fund | 0.28% |
| Income Fund of America | 0.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 1.32% |
| Vanguard Group | 0.15% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RHHBF | Roche Holding Ltd | USD 409 | ▲ 0.22% |
| NVSEF | Novartis AG | USD 148.8 | ▲ 2.71% |
| NONOF | Novo-Nordisk A/S | USD 41.6 | ▼ 4.06% |
| NSRGF | Nestle S.A. | USD 96 | ▼ 0.35% |
| LRLCF | L'Oreal Co. | USD 435 | ▲ 1.3% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:51 UTC. This page is informational and not investment advice.